Covance ($CVD) has launched a managed markets service platform designed to help its biopharma and medical device clients deal with managed care organizations, group purchasing outfits, federal and state programs and wholesalers. The industry loses up to 4.4% of its annual revenue due to insufficient processes and contract management systems, Covance said, costing $11 billion a year. More